At Preeclampsia Diagnosis, Total Cell‐Free DNA Concentration is Elevated and Correlates With Disease Severity

BACKGROUND: Placental derived cell‐free DNA (cfDNA), widely utilized for prenatal screening, may serve as a biomarker for preeclampsia. To determine whether cfDNA parameters are altered in preeclampsia, we conducted a case‐control study using prospectively collected maternal plasma (n=20 preeclampsi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolarova, Teodora R., Gammill, Hilary S., Nelson, J. Lee, Lockwood, Christina M., Shree, Raj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475684/
https://www.ncbi.nlm.nih.gov/pubmed/34310191
http://dx.doi.org/10.1161/JAHA.121.021477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475684/
https://www.ncbi.nlm.nih.gov/pubmed/34310191
http://dx.doi.org/10.1161/JAHA.121.021477

Ejemplares similares